The net effect of these alterations caused by Rac1 inhibition is a marked increase in radiosensitivity of pancreatic cancer cells, as demonstrated by caspase 3 activation, production of floating cells and the results of clonogenic survival assays (see Fig. 7–8). Here, RAC1 is linked to pancreatic neoplasm.